Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Clifutinib · HEC73543

Small molecule · Inhibitor of FMS-like tyrosine kinase 3 (FLT3) · developed by Sunshine Lake Pharma Co.

Phase 3 Most advanced trial
SBFM Developer
2 Registered trials

What is Clifutinib?

Clifutinib is an orally bioavailable, selective small molecule inhibitor of FLT3, a receptor tyrosine kinase overexpressed or mutated in acute myeloid leukemia and most B-lineage neoplasms. It binds FLT3 and inhibits its activity, reducing proliferation of FLT3-expressing cancer cells. It is studied in acute myeloid leukemia.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
HEC73543
Drug type
Small molecule
Targets
FMS-like tyrosine kinase 3 (FLT3)
Mechanism
Inhibitor of FMS-like tyrosine kinase 3 (FLT3)
Therapy area
Oncology
Developer
Sunshine Lake Pharma Co., Ltd. (SBFM)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 3
UNII
3BHA83P7NZ

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05586074 Phase 3 Leukemia, Acute Myeloid (AML) Recruiting SBFM
NCT05133882 Phase 1/2 Acute Myeloid Leukemia, Adult Recruiting SBFM

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Acute Myeloid Leukemia, AdultLeukemia, Acute Myeloid (AML)

Other drugs acting on FLT3

More from Sunshine Lake Pharma Co.

Sources

Updated Nov 1, 2026. Something wrong or missing? Report it on the SBFM page.

Follow SBFM, the company behind Clifutinib

See SBFM's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

SBFM catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.